HUTCHMED (China) Limited (HKG:0013)
Hong Kong · Delayed Price · Currency is HKD 21.98
-0.84 (-3.68%)
Nov 21, 2025, 11:59 AM HKT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,811 employees as of December 31, 2024. The number of employees decreased by 177 or -8.90% compared to the previous year.
Employees
1,811
Change (1Y)
-177
Growth (1Y)
-8.90%
Revenue / Employee
2.66M HKD
Profits / Employee
2.06M HKD
Market Cap
19.43B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,811 | -177 | -8.90% |
| Dec 31, 2023 | 1,988 | -37 | -1.83% |
| Dec 31, 2022 | 2,025 | 265 | 15.06% |
| Dec 31, 2021 | 1,760 | 480 | 37.50% |
| Dec 31, 2020 | 1,280 | 427 | 50.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 24,379 |
| CSPC Pharmaceutical Group | 21,400 |
| WuXi Biologics | 12,575 |
| BeOne Medicines AG | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| Innovent Biologics | 5,659 |
| JD Health International | 3,564 |
| Akeso | 3,035 |
HUTCHMED (China) News
- 13 days ago - HUTCHMED Breaks Below 200-Day Moving Average - Notable for HCM - Nasdaq
- 16 days ago - Hutchmed (HCM) Completes Enrollment for Global Phase III Lung Cancer Study - GuruFocus
- 16 days ago - HUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025 Transcript - Seeking Alpha
- 16 days ago - HUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025 - Slideshow - Seeking Alpha
- 18 days ago - HUTCHMED (HCM) Reveals Significant R&D Advancements in Cancer Treatment - GuruFocus
- 18 days ago - HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event - GlobeNewsWire
- 20 days ago - HUTCHMED (China) Limited (HCM) Discusses Antibody Targeted Therapy Conjugates Platform and Lead Candidate HMPL-A251 in R&D Update Transcript - Seeking Alpha
- 20 days ago - HUTCHMED (China) Limited (HCM) Discusses Antibody Targeted Therapy Conjugates Platform and Lead Candidate HMPL-A251 in R&D Update - Slideshow - Seeking Alpha